Norethindrone acetate 1.0 milligram and ethinyl estradiol 10 micrograms as an ultra low-dose oral contraceptive

Obstetrics and Gynecology

Volumn 122, Issue 3, 2013, Pages 601-607

  Archer, David F ^a   Nakajima, Steven T ^a   Sawyer, Allan T ^a   Wentworth, Jeffrey ^a   Trupin, Suzanne ^a   Koltun, William D ^a   Gilbert, Richard D ^a   Ellman, Herman ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL; NORETHISTERONE ACETATE;

ABDOMINAL PAIN; ACNE; ADULT; ANXIETY DISORDER; APPENDICITIS; ARTICLE; BLEEDING; BREAST TENDERNESS; BRONCHITIS; CHOLECYSTITIS; DEEP VEIN THROMBOSIS; DEHYDRATION; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSMENORRHEA; FEMALE; FOOD POISONING; HEADACHE; HUMAN; HYPEREMESIS GRAVIDARUM; HYPOKALEMIA; INFLUENZA; INTENTION TO TREAT ANALYSIS; LATERAL SINUS THROMBOSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; METRORRHAGIA; MULTICENTER STUDY; MYCOSIS; NAUSEA; OPEN STUDY; ORAL CONTRACEPTION; OVARY CYST; PHARYNGITIS; PNEUMONIA; PRIORITY JOURNAL; RADIUS FRACTURE; RHINOPHARYNGITIS; SEPSIS; SIDE EFFECT; SINUSITIS; SPOTTING; STREPTOCOCCAL PHARYNGITIS; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; UTERINE CERVICITIS; VAGINITIS; VEIN THROMBOSIS; VOMITING; WEIGHT FLUCTUATION;

ADOLESCENT; ADULT; CONTRACEPTIVES, ORAL, SYNTHETIC; ETHINYL ESTRADIOL; FEMALE; HUMANS; MENSTRUATION DISTURBANCES; MIDDLE AGED; NORETHINDRONE; PREGNANCY; PREGNANCY RATE; YOUNG ADULT;

EID: 84883238956     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3182a1741c     Document Type: Article

References (13)

1. Grimes DA, Schulz KF. Nonspecific side effects of oral contraceptives: nocebo or noise? Contraception 2011;83: 5-9.
2. Gallo MF, Nanda K, Grimes DA, Lopez LM, Schulz KF. 20 mg versus .20 mg estrogen combined oral contraceptives for contraception. The Cochrane Database of Systematic Reviews 2011, Issue 1. Art. No.: CD003989. DOI: 10.1002/14651858. CD003989.pub4.
3. Burkman RT. Oral contraceptives: current status. Clin Obstet Gynecol 2001;44: 62-72. (Pubitemid 32156083)
4. Westhoff CL, Torgal AH, Mayeda ER, Stanczyk FZ, Lerner JP, Benn EK, et al. Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial. Obstet Gynecol 2010;116: 275-83.
5. Rosenberg M, Waugh MS. Causes and consequences of oral contraceptive noncompliance. Am J Obstet Gynecol 1999;180: 276-9.
6. Rosenberg MJ, Waugh MS. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol 1998;179: 577-82. (Pubitemid 28447229)
7. Dinger J, Minh TD, Buttman N, Bardenheuer K. Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen. Obstet Gynecol 2011;117: 33-40.
8. Nakajima ST, Archer DF, Ellman H. Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe). Contraception 2007;75: 16-22. (Pubitemid 44854856)
9. Heffner LJ. Advanced maternal age - how old is too old? N Engl J Med 2004;351: 1927-9. (Pubitemid 39447130)
10. Bitzer J, Frey B, von Schönau M, Sabler N, Tschudin S. Twenty or thirty microgram ethinyloestradiol in an oral contraceptive: does it make a difference in the mind and the daily practise of gynaecologists and general practitioners? Eur J Contracept Reprod Health Care 2009;14: 258-67.
11. Westhoff CL, Hait HI, Reape KZ. Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive. Contraception 2012;85: 235-9.
12. Archer DF. Vascular dysfunction as a cause of endometrial bleeding. Gynecol Endocrinol 2012;28: 688-93.
13. Lawrie TA, Helmerhorst FM, Maitra NK, Kulier R, Bloemenkamp K, Gülmezoglu AM. Types of progestogens in combined oral contraception: effectiveness and side-effects. The Cochrane Database of Systematic Reviews 2011, Issue 5. Art. No.: CD004861. DOI: 10.1002/14651858.CD004861.pub2.